Table 1.

Patient demographicsa

PatientAge (yr)Months on DialysisCause of ESRFAtherosclerotic Vascular DiseaseDiagnosed IHDLVMI (g/m2.7)AngiogramAntianginal or BP-Lowering Drugs
27160UnknownYY (angina)52.1NFelodipine 10 mg once daily, atenolol 50 mg once daily
37233DiabetesNN55.3NValsartan 150 mg once daily
47119DiabetesYY (MI)96.7YbDiltiazem 90 mg once daily
8666DiabetesYN61.9NDiltiazem 300 mg, doxazosin 4 mg once daily, irbesartan 150 mg once daily
95517UnknownNN55.8NNifedipine 60 mg once daily, ramipril 10 mg once daily
Mean ± SD or n (%)65 ± 1129 ± 194 (40)2 (20)58.2 ± 201 (10)
  • a APKD, adult polycystic kidney disease; ESRF, end-stage renal failure; GBM, glomerular basement membrane; IHD, ischemic heart disease; LVMI, left ventricular mass index; MI, myocardial infarction.

  • b Angiogram result for patient 4: Diffuse three-vessel disease, not suitable for intervention.

  • c Patient 6 had had a dipyridamole stress test 12 mo before entering the study, which was negative.